4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000081
CFO and Secretary sold 73,678 shares at an average $14.62 ($1,077,477)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Adam Scott CFO and Secretary | 2025-07-28 | Sale | −12,946 | $14.04 | $181,803 | 193,666 | D |
| Levy Adam Scott CFO and Secretary | 2025-07-29 | Sale | −807 | $14.00 | $11,302 | 192,859 | D |
| Levy Adam Scott CFO and Secretary | 2025-07-30 | Sale | −51,500 | $14.70 | $757,168 | 141,359 | D |
| Levy Adam Scott CFO and Secretary | 2025-07-30 | Sale | −8,425 | $15.10 | $127,203 | 132,934 | D |
| Open-market sales · 73,678 sh · avg $14.62 · $1,077,477 | |||||||
Loading xslF345X05/wk-form4_1753920718.xml…